Inhibition of parathyroid hormone-related protein release by extracellular calcium in dispersed cells from human parathyroid hyperplasia secondary to chronic renal failure and adenoma.
The relationship between parathyroid hormone-related protein (PTHrP) release from parathyroid cells and extracellular calcium ion concentration was investigated in three cases of parathyroid hyperplasia secondary to chronic renal failure and in four cases of parathyroid adenoma. Amounts of PTHrP released from individual parathyroid cells dispersed from surgical specimens were estimated by cell immunoblot assay. Parathyroid cells from both hyperplasias and adenomas showed significant suppression in the release of PTHrP with increase in extracellular calcium ions, but the amounts of PTHrP released from adenoma cells were significantly larger than from hyperplasia cells. The maximal value for PTHrP released within 120 minutes from adenoma cells was 2.91 +/- 2.11 x 10(-2) fmol/cell ([Ca2+], 0.4 mmol/L), and the minimal value was 1.32 +/- 0.35 x 10(-2) fmol/cell ([Ca2+], 2.0 mmol/L). On the other hand, the maximal value for PTHrP released from hyperplasia cells was 1.79 +/- 1.56 x 10(-2) fmol/cell ([Ca2+], 0.4 mmol/L), and the minimal value was 0.32 +/- 0.19 x 10(-2) fmol/cell ([Ca2+], 2.0 mmol/L). These results demonstrate actual release of PTHrP from abnormal parathyroid tissues into the extracellular space with the response to extracellular calcium ions depending on the cell status. Given the lack of definite histological criteria to differentiate between hyperplasias and adenomas in the parathyroid gland, the presently demonstrated significant difference in the ability to release PTHrP is important in pointing to parathyroid hyperplasia secondary to chronic renal failure as a distinct pathological entity separate from parathyroid adenoma.
Matsushita
H
H
Department of Pathology, Toranomon Hospital, Tokyo, Japan.
Hara
M
M
Honda
K
K
Kuroda
M
M
Usui
M
M
Nakazawa
H
H
Hara
S
S
Shishiba
Y
Y
D000236:Adenoma / Q000378:metabolism* / Q000473:pathology; D002118:Calcium / Q000378:metabolism / Q000502:physiology*; D002478:Cells, Cultured; D006801:Humans; D006965:Hyperplasia / Q000209:etiology / Q000378:metabolism; D007106:Immune Sera / Q000276:immunology; D015151:Immunoblotting / Q000379:methods; D007676:Kidney Failure, Chronic / Q000150:complications / Q000473:pathology; D010280:Parathyroid Glands / Q000473:pathology*; D010281:Parathyroid Hormone / Q000037:antagonists & inhibitors / Q000096:biosynthesis*; D044162:Parathyroid Hormone-Related Protein; D010282:Parathyroid Neoplasms / Q000378:metabolism; D011506:Proteins / Q000037:antagonists & inhibitors* / Q000276:immunology / Q000378:metabolism*
D007106:Immune Sera; C470121:PTHLH protein, human; D010281:Parathyroid Hormone; D044162:Parathyroid Hormone-Related Protein; D011506:Proteins; D002118:Calcium